Increased expression of CD25 and HLA-DR on lymphocytes recruited into the peritoneal cavity in non-infected CAPD patients

Inflammation

Volumn 25, Issue 6, 2001, Pages 399-404

  Brauner, A ^a   Hylander, B ^a   Jacobson, S H ^a   Moshfegh, A ^a   Lundahl, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD25; Continuous ambulatory peritoneal dialysis; HLA DR; Lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; BIOLOGICAL MARKER; HLA DR ANTIGENS; RECEPTORS, INTERLEUKIN 2;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; UREMIA; ADULT; AGED; ANTIGEN PRESENTATION; CASE CONTROL STUDY; CYTOLOGY; IMMUNOLOGY; KIDNEY FAILURE; LYMPHOCYTE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PERITONEAL CAVITY; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN PRESENTATION; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOTAXIS, LEUKOCYTE; FEMALE; HLA-DR ANTIGENS; HUMAN; KIDNEY FAILURE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGE; PERITONEAL CAVITY; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RECEPTORS, INTERLEUKIN-2; SUPPORT, NON-U.S. GOV'T; UP-REGULATION; UREMIA;

EID: 0035205921     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012806815330     Document Type: Article

References (23)

1. Dysfunction of polymorphonuclear leukocytes in uremia
2. Mortality and causes of death in patients with end-stage renal failure
3. Comparison of peritonitis rates using standard spike versus Y sets in CAPD
4. Peritonitis in children on continuous ambulatory peritoneal dialysis
5. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD)
6. In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients
7. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients
8. Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure
9. Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration
10. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro
11. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes
12. Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination
13. The beta 1-integrin (CD29) receptors: Mediators of T lymphocyte-extracellular matrix recognition that affect adhesion, activation and lymphokine secretion
14. Immune dysfunction in uremia
15. Defective cellular immunity in renal failure: Depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum
16. Immunosuppressive factors in uraemic sera are composed of both dialysable and non-dialysable components
17. Myoinositol may be a factor in uremic immune deficiency
18. Difference in the blood monocyte phenotype between uremic patients and healthy controls: Its relation to monocyte differentiation into macrophages in the peritoneal cavity
19. Presence of preactivated T cells in hemodialyzed patients: Their possible role in altered immunity
20. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression
21. Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD)
22. Diminished adhesion of CD4+ T cells from dialysis patients to extracellular matrix and its components fibronectin and laminin
23. Dialysis-induced serum factors inhibit adherence of monocytes and granulocytes to adult human endothelial cells